HAI: Multi Drug Resistant Gram Negatives

315

A Qualitative Study of Infection Prevention Perceptions, Beliefs, and Practices in the Emergency Department
Stephen Liang, MD, MPHS ; Katherine Brown, MPH ; Jennifer Williams, PhD, RN, ACNS-BC ; Josephine Fox, RN, MPH ; David K. Warren, MD, MPH, FIDSA, FSHEA ; Aimee James, PhD, MPH

Posters

ID Week 2016 ED infection prevention qualitative final.pdf (246.2 kB)

316

Epidemiology of Resistance to Metronidazole in Clinical Isolates of Bacteroides fragilis in a New York City Hospital
Sharon Vuppula, MD ; Carla Lee, MD, MPH ; Henry Pollack, MD

317

Clinical Characteristics of a Military Trauma Cohort with Stenotrophomonas maltophilia Infection
Shane Patterson, M.D. ; Katrin Mende, PhD ; Ping Li, MS ; Dan Z. Lu, MS ; Clinton K. Murray, MD, FIDSA ; David Tribble, MD, DrPH, FIDSA ; Dana M. Blyth, M.D.

Posters

Clinical steno ID Week poster.pdf (612.8 kB)

318

Burden and risk factors of multi-drug resistant gram-negative organisms in Veterans with spinal cord injury
Charlesnika Evans, PhD, MPH ; Margaret Fitzpatrick, MD, MS ; Linda Poggensee, MS ; Swetha Ramanathan, MPH ; Sherri Lavela, PhD MPH MBA ; Stephen Burns, MD ; Makoto Jones, MD, MS ; Katie J. Suda, PharmD, M.S.

Posters

Evans 10-16final.pdf (785.4 kB)

319

Outcome of Initial Antibiotic Treatments among Hospitalized Patients with Hospital- and Healthcare-Associated Bacterial Infections in Brazil: Findings of the RECOMMEND Study
Sudeep Karve, PhD ; Kellie Ryan, MPH ; Esther Pascual, PhD ; Pascale Peeters, MD ; Sonia Rojas-Farreras, MSc ; Elisa Baelen, MSc ; Jesus Rodriguez-Bano, MD

Posters

Brazil RECOMMEND IDWeek 2016 poster_FOR UPLOAD.pdf (333.3 kB)

321

Acinetobacter baumannii Infection Among Critically Ill Cancer Patients In Intensive Care Settings In Pakistan: A Case-Control Comparison Of Risk Factors And Outcomes
Aun Raza, MBBS, FCPS ; Amjad Mahboob, MBBS, FCPS ; Faisal Sultan, MD, DABIM, DABID, FRCP ; Sayed Hammad Nazeer, MD, DABIM, DABID ; Irfaan Mobein, Mbbs ; Waleed Zafar, Mbbs.MPH.

322

Understanding the Role of Host Human Products on the Acquisition of Resistance Traits through Natural Transformation in Acinetobacter baumannii.
Brettni Quinn, BS ; German Matias Traglia, MS ; Meaghan Nguyen, Undergraduate Student ; Alonso Soler Bistue, PhD ; Maria Soledad Ramirez, PhD-Assistant professor

323

Measuring the Prevalence of Multidrug Resistant Acinetobacter (MDRA) Using OXA 23 and OXA 51 Gene Identification in Healthcare Facilities (HCF) in Washington DC
Jacqueline Reuben, MHS ; Nancy Donegan, MPH ; Jo Anne Nelson, DC ; Brendan Sinatro, MPH ; Morris Blaylock, Ph.D. ; Kimary Harmon, MBA, MPH

Posters

323 IDWkMDRA.pdf (734.3 kB)

324

Trend of multidrug-resistant pathogens in critically ill patients transferred from long-term care facilities: A single ICU study, South Korea
Jin Ju Park, M.D. ; Young Kyun Choi, M.D. ; Yu Bin Seo, M.D. ; Jacob Lee, M.D.

325

Prevalence of Multi-Drug Resistant Organisms (MDROs) Using an Antibiotic Resistant Gene Assay at a Tertiary Care Center
Joseph Timpone, M.D. ; Rebecca Kumar, M.D. ; Deepa Lazarous, M.D. ; Seble Kassaye, MD, MS ; Puneet Agarwal, M.D. ; Roshni Biswas, MBBS, MPH ; Amanda Finnell, BS ; Mary Mcfadden, R.N., MHA ; Princy Kumar, M.D.

Posters

Timpone Poster 10 17 2016 (2).pdf (966.8 kB)

326

Stenotrophomonas maltophilia Resistance in Military Trauma Patients
Shane Patterson, M.D. ; Katrin Mende, PhD ; Ping Li, MS ; Dan Z. Lu, MS ; Clinton K. Murray, MD, FIDSA ; David R. Tribble, MD, DrPH, FIDSA ; Dana M. Blyth, M.D.

Posters

Micro steno ID Week poster.pdf (487.1 kB)

327

Trends in Gram-negative Bloodstream Isolates with Limited High-efficacyLow-toxicity Antibiotic Options among Inpatients at 180 US Hospitals
Alicen B. Spaulding, PhD, MPH ; Yi Ling Lai, MPH ; Jennifer Adjemian, PhD ; D. Rebecca Prevots, PhD, MPH ; Tara Palmore, MD ; Chanu Rhee, MD, MPH ; Michael Klompas, MD, MPH, FRCPC, FIDSA ; John P. Dekker, M.D., Ph.D. ; Anthony Suffredini, MD ; David C. Hooper, MD ; Scott Fridkin, MD, FIDSA ; Robert L. Danner, MD ; Sameer S. Kadri, MD, MS.

328

Trends in Multidrug Resistant Bacteria and Clostridium difficile in an Integrated Healthcare Network, 2008-2015
Bert K. Lopansri, MD ; Dominika Swistun, PhD candidate ; Rajesh Mehta, RPh, MS ; Brandon Webb, MD ; Edward Stenehjem, MD, MSc ; Michelle Keane, BS, MBA ; David Pombo, MD ; Kristin Dascomb, MD, PhD ; John Burke, MD, FIDSA, FSHEA

Posters

ID Week Poster 2016 328 Print.pdf (2.9 MB)

329

Development of a Regional Antibiogram to Monitor Burden and Distribution of MDRO Pathogens Across the Spectrum of Care in Los Angeles County
Jessica Silvaggio, MPH ; Dawn Terashita, MD, MPH ; Patricia Marquez, MPH, CIC ; Annemarie Flood, RN, BSN, MPH, CIC ; Job Mendez, RN, MD ; James a. Mckinnell, MD

Posters

LAC Antibiogram 2013 for IDWEEK 2016 FINAL.pdf (2.2 MB)

330

Molecular Epidemiology and Outcomes of Carbapenem Non-Susceptible (CARB-NS) Clinical Isolates in Detroit
Michael Veve, PharmD ; Jeremy Delor, PharmD student ; Robert Tibbetts, Ph.D. D(ABMM), F(CCM) ; Susan L Davis, PharmD

Posters

veve_molEpi_outcomes.pdf (284.3 kB)

331

Incidence of Carbapenem Resistant Enterobacteriaceae (CRE) Bacteremia in Patients Colonized with CRE
Firza Gronthoud, MD ; Eavan Muldoon, MB, BCh, MD, MPH

Posters

IDweek2016 v2.0.pdf (299.9 kB)

332

An Analysis of Carbapenem-Sensitive and Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates Obtained in Stony Brook University Hospital
Elizabeth Diago-Navarro, PhD ; Kaarina I. Hanington, Undergraduate student ; Aisha Khan, D.O, MPH ; Mutayyaba Adnan, Undergraduate student ; Hyun Ah Yoon, MD ; Eric Spitzer, M.D., Ph.D. ; Bettina Fries, MD, FIDSA

333

Impact of expanded Carbapenem Resistant Enterobacteriacae (CRE) screening on Rates of Hospital Acquired (HA) CRE infection
Catherine Passaretti, MD ; Anupama Neelakanta, MD ; Monica Schmidt, MPH, PhD ; Joanne Sitaras, BSN

Posters

CRE_ID_WEEK poster.pdf (138.4 kB)

334

Risk Factor and Outcome Evaluation in Patients with Carbapenem Resistant Enterobacteriaceae (CRE) in a Mid-Western Tertiary Care Academic Medical Center
Madhuri Sopirala, MD, MPH ; Francis Ssali, MD ; Siyun Liao, Pharm.D., PhD, BCPS ; Loretta Simbartl, MS ; Stephen Kralovic, MD, MPH, FSHEA

336

Epidemiology of the emergence of Carbapenemase-producing Enterobacteriaceae in South-central Ontario, Canada
Philipp Kohler, MD ; Roberto Melano, PhD ; Samir N. Patel, PhD, FCCM ; Shumona Shafinaz, MD ; Amna Faheem, MD ; Brenda L. Coleman, PhD ; Karen Green, MSc ; Irene Armstrong, MD, MSc ; Huda Almohri, BSc, MD, FRCPC ; Kevin Katz, MD, CM, MSc, FRCPC ; Freda Lam, MPH, CPHI(C) ; Matthew Muller, MD, PhD ; Jeff Powis, MD, MSc, FRCPC ; Susan Poutanen, MD, MPH ; David Richardson, MD ; Laura Rosella, PhD ; Anu Rebbapragada, PhD ; Alicia Sarabia, MD ; Andrew Simor, MD ; Allison Mcgeer, MD, MSc

Posters

CPE_Poster_12Oct2016.pdf (277.2 kB)

337

Two years of Population-based Surveillance for Carbapenem-resistant Enterobacteriaceae (CRE) in Bernalillo County, NM, 2014-2015
Erin C. Phipps, DVM, MPH ; Nicole Kenslow, MPH ; Emily B. Hancock, MS

Posters

Phipps_IDWeek_2016_Final.pdf (317.2 kB)

338

Carbapenem-Resistant Enterobacteriaceae (CRE) and Antimicrobial Usage within the Veterans Affairs (VA) Healthcare System: 2010-2014
Russell Ryono, Pharm. D. ; Gina Oda, MS ; Patricia Schirmer, MD ; Cynthia Lucero-Obusan, MD ; Mark Holodniy, MD, FIDSA, FSHEA

339

Carbapenem-resistance in Enterobacteriaceae among hospitalized patients with urinary tract infection, pneumonia and sepsis increases the risk of receiving inappropriate empiric treatment
Marya D. Zilberberg, MD, MPH ; Brian Nathanson, PhD ; Kate Sulham, MPH ; Weihong Fan, MS ; Andrew F. Shorr, MD, MPH

Posters

Medicine_poster_CRE .pdf (110.4 kB)

340

A comprehensive, intensive patient surveillance program for carbapenemase-producing bacteria at the NIH Clinical Center
Robin T. Odom, M.S. ; Amanda M. Ramsburg, B.S.N. ; Anna F. Lau, Ph.D. ; John P. Dekker, M.D., Ph.D. ; Angela V. Michelin, M.P.H. ; Mary Ann Bordner, M.S. ; David K. Henderson, M.D. ; Karen M. Frank, M.D., Ph.D. ; Tara N. Palmore, MD

Posters

CPO Surveillance Poster IDWeek2016 FINAL (PRINT VERSION).jpg (2.9 MB)

342

Recurrence of Positive Cultures for Carbapenem-resistant Enterobacteriaceae (CRE) in Atlanta
Mary Elizabeth Sexton, MD ; Chris Bower, MPH ; Jesse T. Jacob, MD

Posters

Recurrence Poster.pdf (471.6 kB)

343

What's Lurking Around the Corner: Identifying Novel CRE Resistance Mechanisms in the Los Angeles County Healthcare Community, 2015
Patricia Marquez, MPH, CIC ; Nicole Green, PhD, D(ABMM) ; Dawn Terashita, MD, MPH ; Sandeep Bhaurla, MPH ; Laurene Mascola, MD, MPH

Posters

IDWeek_CREtestingLAC.pdf (261.7 kB)

344

Assessing Carbapenemase Resistant Enterobacteriaceae (CRE) Prevalence Using a Combined Antibiotic Resistance Gene Assay and Surveillance Cultures in Hospitalized Patients
Rebecca Kumar, M.D. ; Princy Kumar, M.D. ; Deepa Lazarous, M.D. ; Puneet Agarwal, M.D. ; Roshni Biswas, MBBS, MPH ; Seble Kassaye, MD, MS ; Allen Chao, BS, MS ; Kelly Wang, BS ; Amanda Finnell, BS ; Mary Mcfadden, R.N., MHA ; Joseph Timpone, M.D.

345

Colonization with Carbapenem-Resistant Enterobacteriaceae (CRE) Increases the Risk of Bloodstream Infections with CRE
Rossana Rosa, MD ; Jose Castro, MD, FIDSA ; Dennise Depascale, MT ; Adriana Jimenez, MPH, MLS (ASCP), CIC. ; L. Silvia Munoz-Price, MD, PhD

Posters

CRE_IDW16_poster.pdf (618.1 kB)

346

Impact of Rectal Colonization with Highly Drug-resistant Enterobacteriaceae on Post-transplant Infections: The Carbapenem Resistant Enterobacteriaceae Carriage in Solid Organ Transplant (CREST) Study
M. Hong Nguyen, MD ; Ryan K. Shields, PharmD ; Liang Chen, PhD ; Barry N. Kreiswirth, PhD ; Cornelius Clancy, MD

347

Risk Factors for Mortality in Patients with Urinary and Sterile Site Cultures Positive for Carbapenem-resistant Enterobacteriaceae (CRE) in Atlanta, 2011-2014
Mary Elizabeth Sexton, MD ; Chris Bower, MPH ; Jesse T. Jacob, MD

Posters

Mortality Poster.pdf (464.5 kB)

348

Predicting Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage at the Time of Admission Using a State-Wide Hospital Discharge Database
Michael Y. Lin, MD, MPH ; Serena Rezny, MS ; Michael J. Ray, MPH ; Dejan Jovanov, BSc ; Robert A. Weinstein, MD ; William E. Trick, MD

349

Carbapenem resistant Enterobacteriaceae (CRE) in the Veterans Health Administration (VHA): a “second epidemic” of carbapenem resistance among Enterobacter cloacae after that of Klebsiella pneumoniae
Federico Perez, MD ; Brigid Wilson, PhD ; Sachin Patel, MD ; Elie Saade, MD, MPH ; Curtis J. Donskey, MD ; Robert A. Bonomo, MD

Posters

Slide1.GIF (1.2 MB)

350

Surveillance for Carbapenem-Resistant Pseudomonas aeruginosa at Five U.S. Sites – 2015
Maroya Spalding Walters, PhD ; Sandra Bulens, MPH ; Emily B. Hancock, MS ; Erin C. Phipps, DVM, MPH ; Daniel Muleta, MD, MPH ; Jacquelyn Mounsey, BSN, RN, CCRP ; Marion Kainer, MBBS, MPH, FSHEA ; Cathleen Concannon, MPH ; Ghinwa Dumyati, MD, FSHEA ; Chris Bower, MPH ; Jesse T. Jacob, MD ; P. Maureen Cassidy, MPH ; Zintars G. Beldavs, MS ; Uzma Ansari, MS ; Valerie Albrecht, MPH ; Maria S. Karlsson, PhD ; J. Kamile Rasheed, PhD ; Alexander Kallen, MD, MPH

351

Carbapenem-resistant Enterobacteriaceae reported to the National Healthcare Safety Network multidrug-resistant organism module, January 2013–December 2015
Amber Vasquez, MD, MPH ; Maroya Walters, PhD ; Alexander Kallen, MD, MPH

352

National Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) in the Ambulatory and Acute Care Settings in the United States in 2015
Holly Hoffman-Roberts, PharmD ; Melanie Olesky, PhD ; Ying P. Tabak, PhD ; John Mohr, PharmD ; Richard S Johannes, MD, MS ; Vikas Gupta, Pharm.D., BCPS

Posters

Tetraphase CRE 352 10-21-16.pdf (208.4 kB)

353

A Cluster of Carbapenemase-Producing Enterobacter cloacae ST171 at a Tertiary Care Center Demonstrating an Ongoing Regional Threat
Edwin C Pereira, MD ; Melissa Hargreaves, PhD ; Jeana Houseman, MHSA, DLM(ASCP), CIC ; Timothy Johnson, PhD ; Ruth Lynfield, MD, FIDSA ; Paula Snippes Vagnone, MT (ASCP) ; Medora Witwer, MPH ; Susan Kline, MD, MPH, FSHEA

Posters

IDWeek poster - PEREIRA.pdf (272.0 kB)

355

Association between Carbapenem Resistance and Mortality among Adults Hospitalized with Serious Infections due to an Enterobacteriaceae spp: Results of a Systematic Literature Review and Meta-Analysis
Amber Martin, BS ; Kyle Fahrbach, PhD ; Qi Zhao, MD, MPH ; Thomas Lodise, PharmD, PhD

Posters

Burden of CRE IDW16(AVY16075.3001).pdf (1.3 MB)

356

How Frequently Does Hospitalization of Patients Colonized with Carbapenemase-Producing Enterobacteriaceae (CPE) Result in Contamination of Hospital Sink Drains?
Lorraine Maze Dit Mieusement, RN, MN, CIC ; Allison Mcgeer, MD, MSc ; Barbara Willey, ART

Posters

IDWeek_CPEinDrains_FINAL.pdf (682.5 kB)

357

Incomplete Adoption of Clinical Laboratory Standards Institute (CLSI) Breakpoints to Detect Carbapenem Resistant Organisms
James a. Mckinnell, MD ; Janet Hindler, MCLS, MT(ASCP) ; Erin Epson, MD ; Sam Horwich-Scholefield, MPH, CIC ; Loren Miller, MD, MPH ; Job Mendez, RN, MD ; Jeremias Martinez, BS ; Jacob Sinkowitz, HSD ; Dawn Terashita, MD, MPH ; Patricia Marquez, MPH, CIC ; Sandeep Bhaurla, MPH ; Marcelo Moran, MA, MPH ; Lindsey Pandes, MPH ; Christina Hershey, BA ; Romney Humphries, PhD

Posters

CLSI Standards IDWEEK 2016 - for Printing.ppt.pdf (1.0 MB)

358

blaVIM-producing Enterobacter cloacae in Ontario, Canada: Links between Sewage, Surface Water, and Human Isolates
Philipp Kohler, MD ; Hyunjin Kim, BSc ; Roberto Melano, PhD ; Jennie Johnstone, MD ; Samir Patel, PhD ; Nathalie Tijet, PhD ; Barbara Willey, ART ; Brenda Coleman, PhD ; Karen Green, MSc ; Irene Armstrong, MD, MSc ; Kevin Katz, MD, CM, MSc, FRCPC ; Matthew P. Muller, MD, PhD, FRCPC ; Jeff Powis, MD, MSc, FRCPC ; Susan Poutanen, MD, MPH ; David Richardson, MD ; Alicia Sarabia, MD ; Andrew E. Simor, MD, FRCPC, FACP ; Allison Mcgeer, MD, MSc

Posters

VIM_Poster_12Oct2016.pdf (361.2 kB)

359

Emerging Waves of Carbapenem Resistance among Gram-negative Pathogens at a Tertiary Center
Ryan K. Shields, PharmD ; Lloyd Clarke, BScHons ; Julie Paronish, MPH ; Cornelius J. Clancy, MD ; Minh-Hong Nguyen, MD

360

Pseudomonas aeruginosa Non-susceptibility to Common Antibiotics by Source in USA Hospitals in 2015: A Multicenter Study
Sanjay Merchant, PhD ; Ying P. Tabak, PhD ; C. Andrew Deryke, PharmD ; Daryl D. Depestel, PharmD, BCPS-ID ; Richard S Johannes, MD, MS ; Pamela Moise, PharmD ; Vikas Gupta, Pharm.D., BCPS

Posters

Merck PSA NS ID Week Poster v6 FINAL 10-24-16.pdf (320.1 kB)

361

Multidrug Resistant Pseudomonas aeruginosa (MDR-PSA) in USA Hospitals by Geographic Region in 2015
C. Andrew Deryke, PharmD ; Daryl D. Depestel, PharmD, BCPS-ID ; Ying P. Tabak, PhD ; Sanjay Merchant, PhD ; Richard S Johannes, MD, MS ; John Jay Hawkshead III, DrPH ; Pamela Moise, PharmD ; Vikas Gupta, Pharm.D., BCPS

Posters

BD MDR PSA ID Week Poster v4 FINAL 10-24-16.pdf (286.3 kB)

362

Carbapenem-resistant Gram-negative Pathogens among Hospitalized Patients in the United States between 2010 and 2015
Bin Cai, MD, MPH, MS, PhD ; Roger Echols, MD, FIDSA ; Gareth Morgan, Ph.D ; Juan Camilo Arjona Ferreira, MD ; Mari Ariyasu, Ph.D ; Takuko Sawada, BA ; Tsutae Den Nagata, MD, PhD, FFPM

Posters

362_IDWPOSTER.pdf (788.4 kB)

363

Impact of Institutional Carbapenem Usage on Pseudomonas aeruginosa Resistance
Tara Lindeman, Pharm.D. ; Travis W. Linneman, Pharm.D. ; Ryan P. Moenster, Pharm.D.

364

Therapeutic Management of Bloodstream Infection Resulting from Pseudomonas aeruginosa that is Non-Susceptible to Carbapenems but Susceptible to Cephalosporins and/or to Penicillins
Asaf Miller, MD ; Hadas Ofer-Friedman, MD ; Ronit Zaidenstein, M.D. ; Mor Dadon, BsC ; Dror Marchaim, MD

Posters

ID-Week poster - PA BSI - Carb-R b-Lactam-S 10-11-2016 1 dm.pdf (524.8 kB)

365

Regional Difference of Extended-spectrum β-lactamases (ESBLs) Susceptibility in USA Hospitals in 2015
Daryl D. Depestel, PharmD, BCPS-ID ; Ying P. Tabak, PhD ; C. Andrew Deryke, PharmD ; Sanjay Merchant, PhD ; Richard S Johannes, MD, MS ; Pamela Moise, PharmD ; Vikas Gupta, Pharm.D., BCPS

Posters

BD ESBL ID Week Poster v5 FINAL 10-24-16.pdf (328.1 kB)

366

Sites of Colonization in Hospitalized Patients with Infections Caused by Extended-Spectrum Beta-Lactamase Producing Escherichia coli and Klebsiella pneumoniae
Zeina Kanafani, MD ; Sukayna Fadlallah, MS ; Sarah Assaf, MD ; Khalil Anouti, MD ; Kohar Annie Kissoyan, MS ; Jad Sfeir, MD ; Tamara Nawar, MD ; Mohamad Yasmin, MD ; Ghassan Matar, PhD

Posters

Poster.pdf (849.6 kB)

367

The Predictive Utility of Screening ESBL Swabs in Selecting Empiric Antibiotics for Sterile-Site Infections
Ian Brasg, MD ; Marion Elligsen, RPh ; Derek Macfadden, MD ; Nick Daneman, MD, MSc

Posters

IDWeek 2016 ESBL Oct 23.pdf (281.6 kB)

368

Differences in Clinical Presentation and Outcome Between Extended Spectrum β-lactamase (ESBL) vs non-ESBL Urinary Tract Infections (UTI) in a Medically Underserved Population
Emi Minejima, PharmD ; Annie Wong-Beringer, PharmD

369

National Prevalence of Extended Spectrum Beta-lactamase Producing Enterobacteriaceae (ESBL) in the Ambulatory and Acute Care Settings in the United States in 2015
Holly Hoffman-Roberts, PharmD ; Katherine Luepke, PharmD ; Ying P. Tabak, PhD ; John Mohr, PharmD ; Richard S Johannes, MD, MS ; Vikas Gupta, Pharm.D., BCPS

Posters

Tetraphase ESBL 369 10-21-16.pdf (211.4 kB)

370

Antibiotic Resistance and Clinical Presentation of Healthcare-associated Hypervirulent Klebsiella pneumoniae Infection
Hyun Ah Kim, M.D., Ph.D ; Miri Hyun, MD ; Hyo-Lim Hong, MD ; Hyun Hee Kwon, MD, Ph.D ; Seong Yeol Ryu, M.D., Ph.D

371

Bacteremia due to Escherichia coli with the plasmid-mediated colistin resistance (COL-R) mcr-1 gene
Andrea Vila, MD ; Cynthia V Rivero, MD ; Mariana Chumbita, resident ; Juan Ignacio Dapás, MD ; Hugo Pagella, Bioquemistry ; Fernando Pasterán, Bioquemistry ; Alejandra Corso, Bioquemistry

Posters

mcr1.pdf (4.6 MB)

372

Molecular characterization of fecal Escherichia coli isolates from households (HHs) of veterans within which one or more HH members carries E. coli sequence type 131 (ST131) or other fluoroquinolone (FQ)-resistant E. coli (FQREC)
Muhanad Mohamed, MD ; Connie Clabots, BS MT(ASCP) ; Stephen B. Porter, MS ; James R. Johnson, MD, FIDSA, FACP, FRCPE

Posters

IDWeek_CVAST_2016_Poster.Muhanad.Final.pdf (6.1 MB)

373

Surveillance for Multidrug-Resistant Gram-negative Bacilli: Use of Selective Screening Agar Increases the Rate of Detection and Decreases Cost of Screening
Ishminder Kaur, M.D. ; Jennifer Vodzak, MD ; Kaushik Patel, MT ; Sarah S. Long, MD ; Jane M. Gould, MD ; Alan T. Evangelista, PhD

Posters

VACC Poster Kaur 36X60.pdf (828.4 kB)

374

Temporal trends in Ceftriaxone resistant Escherichia coli infections
Sumanth Rajagopal, MD ; G.Thomas Ray, MBA ; Roger Baxter, MD, FIDSA

Posters

374, IDWEEK 2016.pdf (310.4 kB)

375

Characteristics and Predictive Factors for Multidrug-Resistant Gram-Negative Infections in Deployment-Related Trauma Patients
Wesley Campbell, MD ; Ping Li, MS ; Timothy Whitman, DO ; Dana M. Blyth, M.D. ; Elizabeth Schnaubelt, MD ; Katrin Mende, PhD ; David R. Tribble, MD, DrPH, FIDSA

376

Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin-Resistant Infections caused by Enterobacteriaceae Species Other than Escherichia coli and Klebsiella pneumoniae
Amanda Adler, BA ; Xuan Qin, PhD ; Scott Weissman, MD ; Matthew Kronman, MD, MSCE ; Arianna Miles-Jay, MPH ; Carey-Ann D. Burnham, PhD ; Alexis Elward, MD, MPH, FSHEA ; Jason Newland, MD, MEd, FPIDS ; Rangaraj Selvarangan, PhD ; Kaede V. Sullivan, MD ; Theoklis Zaoutis, MD, MSCE ; Danielle Zerr, MD, MPH, FPIDS

Posters

IDSA_poster_10_18_16.pdf (766.6 kB)

377

Multi-Drug Resistant Escherichia Coli In Northern Nevada Acute Care Facilities
James Wilson V, MD FAAP ; Jacquelyn Bonde, MPH

378

National Prevalence of Multidrug-Resistance (MDR) in Enterobacteriaceae (ENT) in the Ambulatory and Acute Care Settings in the United States in 2015
Hina Patel, PharmD ; Holly Hoffman-Roberts, PharmD ; Ying P. Tabak, PhD ; John Mohr, PharmD ; Richard S Johannes, MD, MS ; Vikas Gupta, Pharm.D., BCPS

Posters

MDR ENT 378 10-24-16.pdf (362.8 kB)

Navigation

Browse by Day:

Browse by Track: